Preclinical assessment of a human monoclonal antibody against vascular endothelial growth factor receptor 1 as a therapeutic agent for treating breast cancer.

被引：0
|
作者：
Wu, Y [1 ]
Zhong, ZJ [1 ]
Huber, J [1 ]
Bassi, R [1 ]
Finnerty, B [1 ]
Carrick, F [1 ]
Tonra, J [1 ]
Hicklin, D [1 ]
机构：
[1] ImClone Syst Inc, New York, NY USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9144S / 9144S
页数：1
相关论文
共 50 条
  • [1] Production of neutralizing monoclonal antibody against human vascular endothelial growth factor receptor Ⅱ
    Rong LI
    ActaPharmacologicaSinica, 2004, (10) : 52 - 58
  • [2] Production of neutralizing monoclonal antibody against human vascular endothelial growth factor receptor II
    Li, R
    Xiong, DS
    Shao, XF
    Liu, J
    Xu, YF
    Xu, YS
    Liu, HZ
    Zhu, ZP
    Yang, CZ
    ACTA PHARMACOLOGICA SINICA, 2004, 25 (10) : 1292 - 1298
  • [3] Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer
    Wu, Yan
    Zhong, Zhaojing
    Huber, James
    Bassi, Rajiv
    Finnerty, Bridget
    Corcoran, Erik
    Li, Huiling
    Navarro, Elizabeth
    Balderes, Paul
    Jimenez, Xenia
    Koo, Henry
    Mangalampalli, Venkata R. M.
    Ludwig, Dale L.
    Tonra, James R.
    Hicklin, Daniel J.
    CLINICAL CANCER RESEARCH, 2006, 12 (21) : 6573 - 6584
  • [4] Vascular endothelial growth factor and bevacitumab in breast cancer.
    Bando H.
    Breast Cancer, 2007, 14 (2) : 163 - 173
  • [5] Vascular endothelial growth inhibitor (VEGI), an antiangiogenic factor, in human breast cancer.
    Parr, C
    Gan, C
    Harrison, G
    Jiang, WG
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S74 - S74
  • [6] A comparison of the native peptide ligand and a monoclonal antibody (mAb) against the epidermal growth factor receptor (EGFR) for imaging human breast cancer.
    Reilly, RM
    Kiarash, R
    Sandhu, J
    Gariépy, J
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 77P - 77P
  • [7] Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor
    Lin, YS
    Nguyen, C
    Mendoza, JL
    Escandon, E
    Fei, D
    Meng, YG
    Modi, NB
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 288 (01): : 371 - 378
  • [8] Vascular Endothelial Growth Factor Receptor-1 in Human Cancer
    Schwartz, Jonathan D.
    Rowinsky, Eric K.
    Youssoufian, Hagop
    Pytowski, Bronislaw
    Wu, Yan
    CANCER, 2010, 116 (04) : 1027 - 1032
  • [9] Vascular Endothelial Growth Factor Receptor-1 Expression in Breast Cancer and Its Correlation to Vascular Endothelial Growth Factor A
    Srabovic, Nahida
    Mujagic, Zlata
    Mujanovic-Mustedanagic, Jasminka
    Softic, Adaleta
    Muminovic, Zdeno
    Rifatbegovic, Adi
    Begic, Lejla
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2013, 2013
  • [10] Soluble Vascular Endothelial Growth Factor Receptor 1 in Human Breast Milk
    Ozgurtas, Taner
    Aydin, Ibrahim
    Turan, Ozden
    Koc, Esin
    Hirfanoglu, Ibrahim M.
    Acikel, Cengiz H.
    Akyol, Mesut
    Serdar, Muhittin
    Erbil, Kemal M.
    HORMONE RESEARCH IN PAEDIATRICS, 2011, 76 (01): : 17 - 21
12345